Prostate Cancer
Researchers Stress Specificity of Grail Multi-Cancer Detection Test in Response to Study Criticism
Premium
The authors of a commentary said they view recent study results as informative, though limited, regarding the test's performance in prostate cancer.
The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.
Kairos Pharma, PreCheck Health Services to Develop CDx for Prostate, Lung Cancer Drug
PreCheck will help the biopharma firm confirm and validate biomarkers previously identified in early-phase trials for companion diagnostic use.
Phosphoproteomic Studies Point to Subtypes, Treatment Targets for Gastric, Prostate Cancer
Two independent research teams characterized proteomic and phosphoproteomic patterns in the two cancer types using matched tumor and normal tissues.
Novigenix to Develop Prostate Cancer Liquid Biopsy Test With €1.8M Eurostars Consortium Grant
The company is working with investigators at Radboud University to validate an RNA liquid biopsy test to better tailor therapy in advanced castration-resistant prostate cancer.